Chemicals giant Bayer AG announced on Aug. 16 it would ask the Supreme Court to overturn an appeals court ruling that upheld damages to a customer blaming his cancer on Roundup, a glyphosate-based weed-killer that has been on the market since the 1970s, in a move aimed at stemming a potential wave of cancer-related lawsuits against it.
Bayer reached a settlement deal in principle with plaintiffs last year but failed to secure court approval for a separate agreement on how to handle future cases, Reuters reports.
